{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:05:07Z","timestamp":1793927107731,"version":"4.8.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:p>\n                    Metabolic syndrome (MetS) definitions may perform differently in indigenous populations with distinct genetic and lifestyle exposures. The Negrito community remains under-represented in cardiometabolic research despite emerging risk. Building on earlier observations of atypical biomarker patterns in this population, potentially linked to CDH13-related vascular mechanisms, this study aimed to determine MetS prevalence using the International Diabetes Federation (IDF) and Harmonized Joint Interim Statement (JIS) definitions, evaluate agreement between these definitions and their concordance with cardiovascular risk scores (CRS), and examine relationships between inflammatory and vascular biomarkers in the context of MetS. A cross-sectional study was conducted among Negrito adults. MetS was categorized using the IDF and JIS definitions. CRS included the Framingham risk score (FRS), Castelli risk index (CRI)-I, CRI-II and the atherogenic index of plasma (AIP). High-sensitivity C-reactive protein, lipoprotein(a), soluble intercellular adhesion molecule-1 (sICAM-1), and T-cadherin were quantified. Agreement statistics, correlations, logistic and linear regression models were applied. Among 153 adults, MetS prevalence was 11.8% (IDF) and 16.3% (JIS) with near-perfect agreement (\u03ba\u2005=\u20050.81), although McNemar testing indicated slight asymmetry between definitions. Concordance between MetS and CRS was generally weak, with AIP showing the highest agreement (IDF \u03ba\u2005=\u20050.17; JIS \u03ba\u2005=\u20050.30), followed by CRI-II (IDF \u03ba\u2005=\u20050.05; JIS \u03ba\u2005=\u20050.20). CRI-I showed slight agreement with both definitions (IDF \u03ba\u2005=\u20050.07; JIS \u03ba\u2005=\u20050.15), while FRS showed no meaningful alignment (IDF \u03ba\u2005=\u2005\u22120.07; JIS \u03ba\u2005=\u2005\u22120.01). sICAM-1 showed weak but consistent positive correlations with all CRS (r\u2005=\u20050.20\u20130.26,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.017\u2013.002). T-cadherin did not correlate with CRS but was inversely associated with sICAM-1 (r = \u20130.28,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001). In multivariable logistic models, CRI-I (OR\u2005=\u20053.20), CRI-II (OR\u2005=\u20052.32) and AIP (OR\u2005=\u20052.15) remained independently associated with MetS. In linear models, sICAM-1 showed consistent associations with each CRS (FRS R\n                    <jats:sup>2<\/jats:sup>\n                    \u2005=\u20050.03; CRI-I R\n                    <jats:sup>2<\/jats:sup>\n                    \u2005=\u20050.06; CRI-II R\n                    <jats:sup>2<\/jats:sup>\n                    \u2005=\u20050.06; AIP R\n                    <jats:sup>2<\/jats:sup>\n                    \u2005=\u20050.03). IDF and JIS definitions classified MetS similarly but showed limited concordance with CRS. AIP and CRI demonstrated stronger cross-sectional associations with MetS than FRS. Biomarker analyses indicated that sICAM-1 correlated with CRS. The inverse relationship between T-cadherin and sICAM-1 raises the possibility of compensatory vascular-protective mechanisms. Collectively, these findings suggest a distinct lipid-inflammatory cardiometabolic phenotype in the Negrito population, where endothelial activation markers may capture early vascular stress beyond traditional risk scores.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048546","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:01:13Z","timestamp":1778896873000},"page":"e48546","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic syndrome definitions and cardiovascular risk concordance in the Negrito population: Insights from lipid-derived risk indices, inflammation and endothelial biomarkers"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5663-8108","authenticated-orcid":false,"given":"Atiqah","family":"Mokhsin","sequence":"first","affiliation":[{"name":"Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrian Alif","family":"Faisal","sequence":"additional","affiliation":[{"name":"Pathology Department, Hospital Sultan Haji Ahmad Shah, Temerloh, Pahang, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Mohd Firdaus","family":"Othman","sequence":"additional","affiliation":[{"name":"Specialised Diagnostics Centre, Institute for Medical Research, Wilayah Persekutuan Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor\u2019Ashikin","family":"Othman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Kuala Lumpur, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletza","family":"Mohd Ismail","sequence":"additional","affiliation":[{"name":"Chemical Pathology Unit, Department of Pathology, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia"},{"name":"Hospital Al Sultan Abdullah, Universiti Teknologi MARA, Bandar Puncak Alam, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Wee","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Public Health Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon-Peng","family":"Hoh","sequence":"additional","affiliation":[{"name":"Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, IMU University, Bukit Jalil, Wilayah Persekutuan Kuala Lumpur, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuhairah","family":"Abdul Rahman","sequence":"additional","affiliation":[{"name":"Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia"},{"name":"Chemical Pathology Unit, Department of Pathology, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia"},{"name":"Hospital Al Sultan Abdullah, Universiti Teknologi MARA, Bandar Puncak Alam, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260904","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s10020-024-01019-y","article-title":"The interplay of factors in metabolic syndrome: understanding its roots and complexity.","volume":"30","author":"Islam","year":"2024","journal-title":"Mol Med"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/gbe\/evv065","article-title":"Unravelling the genetic history of Negritos and Indigenous populations of Southeast Asia.","volume":"7","author":"Aghakhanian","year":"2015","journal-title":"Genome Biol Evol"},{"key":"R4-20260904","first-page":"67","article-title":"Copy number variation of FCGR3B on Negrito-Mendriq.","volume":"7","author":"Helmy Bin Yusof","year":"2019","journal-title":"J Acad"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.puhe.2018.10.001","article-title":"Metabolic syndrome and cardiometabolic risk factors among indigenous Malaysians.","volume":"176","author":"Aghakhanian","year":"2019","journal-title":"Public Health"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/nu12010015","article-title":"Ethnicity and metabolic syndrome: implications for assessment, management and prevention.","volume":"12","author":"Lear","year":"2019","journal-title":"Nutrients"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"e021580","DOI":"10.1136\/bmjopen-2018-021580","article-title":"Observational study of the status of coronary risk biomarkers among Negritos with metabolic syndrome in the east coast of Malaysia.","volume":"8","author":"Mokhsin","year":"2018","journal-title":"BMJ Open"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"R10-20260904","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study.","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"R11-20260904","first-page":"5A","article-title":"Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study.","volume":"4","author":"Castelli","year":"1988","journal-title":"Can J Cardiol"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/1047-2797(92)90033-M","article-title":"Lipids and risk of coronary heart disease. the Framingham study.","volume":"2","author":"Castelli","year":"1992","journal-title":"Ann Epidemiol"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.85.1.37","article-title":"Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.","volume":"85","author":"Manninen","year":"1992","journal-title":"Circulation"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00439-014-1459-8","article-title":"The population genomic landscape of human genetic structure, admixture history and local adaptation in Peninsular Malaysia.","volume":"133","author":"Deng","year":"2014","journal-title":"Hum Genet"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"151183","DOI":"10.1016\/j.ejcb.2021.151183","article-title":"Revisiting the multiple roles of T-cadherin in health and disease.","volume":"100","author":"Rubina","year":"2021","journal-title":"Eur J Cell Biol"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial.","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"e022974","DOI":"10.1136\/bmjopen-2018-022974","article-title":"Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.","volume":"8","author":"Zhou","year":"2018","journal-title":"BMJ Open"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"218","DOI":"10.47836\/mjmhs.20.4.27","article-title":"The prevalence of metabolic syndrome and its components among ethnic Dayak community in Sarawak.","volume":"20","author":"Jiun","year":"2024","journal-title":"Malays J Med Health Sci"},{"key":"R25-20260904","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.diabres.2010.11.025","article-title":"Prevalence of metabolic syndrome and its risk factors in adult Malaysians: Results of a nationwide survey.","volume":"91","author":"Mohamud","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.numecd.2019.07.006","article-title":"Association of metabolic syndrome with atherogenic index of plasma in an urban Chinese population: a 15-year prospective study.","volume":"29","author":"Zhang","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R27-20260904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-024-01349-1","article-title":"Comparison of atherogenic indices for predicting the risk of metabolic syndrome in Southwest Iran: results from the Hoveyzeh Cohort Study (HCS).","volume":"16","author":"Babaahmadi\u2010Rezaei","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"R28-20260904","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2011.168559","article-title":"Circulating soluble ICAM-1 and subclinical atherosclerosis: the coronary artery risk development in young adults (CARDIA) study.","volume":"58","author":"Gross","year":"2012","journal-title":"Clin Chem"},{"key":"R29-20260904","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/01.HYP.0000056108.73219.0A","article-title":"Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling.","volume":"41","author":"Kuwahara","year":"2003","journal-title":"Hypertension"},{"key":"R30-20260904","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41374-019-0320-z","article-title":"Blockade of intercellular adhesion molecule-1 prevents angiotensin II-induced hypertension and vascular dysfunction.","volume":"100","author":"Lang","year":"2020","journal-title":"Lab Invest"},{"key":"R31-20260904","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12933-025-02653-4","article-title":"Atherogenic index of plasma, high sensitivity C-reactive protein and incident diabetes among middle-aged and elderly adults in China: a national cohort study.","volume":"24","author":"Wang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R32-20260904","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/03630242.2013.788120","article-title":"Women are at a higher risk of metabolic syndrome in rural Malaysia.","volume":"53","author":"Jan Mohamed","year":"2013","journal-title":"Women Health"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:01:24Z","timestamp":1788530484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":25,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048546","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2026-01-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}